Biotek-snakken — April 2023
-
Jazz, hvad er betingelserne på de warrants i Acarix?
-
Eller mener du den emission som var i januar, Jazz?
-
Uanset, hvad, så er fordelen for Acarix at de ikke har en dyr salgsafdeling, men laver strategiske salgsaftaler med eksisterende salgsorganisationer, og KUN betaler en afgift når de sælger nogle instrumenter
Det holder cashburn noget nede -
-
Redeye comments on Acarix following the near-term announcement of two uplifting press releases, including a SEK9.5m directed share issue and a strategic sales partnership expanding the company’s commercial reach with an additional 30 states. https://www.redeye.se/research/892660/acarix-uplifting-news?utm_source=note&utm_medium=email
-
A strategic sales partnership has been formed between Acarix and CompleMed, LLC, a sales organization that focuses on the US cardiology market. CompleMed will contribute 16 sales teams to Acarix’s organization, expanding its geographic market coverage to 43 states and further increasing Acarix’s US footprint. This move aligns with our expectations that Acarix will significantly increase its sales in the US during the latter half of 2023. Our projections indicate that sales will grow from SEK6m i
-
SEK6m in FY 2022 to approximately SEK42m in FY 2023.
-
2 Top Biotech Stocks to Buy Right Now https://www.proinvestor.com/investornyt/965228/2-top-biotech-stocks-to-buy-right-now
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind